Gene Expression Analysis and Validation of a Novel Biomarker Signature for Early-Stage Lung Adenocarcinoma

Gene Expression Analysis and Validation of a Novel Biomarker Signature for Early-Stage Lung Adenocarcinoma

Lung cancer is responsible for 2.21 million annual cancer cases and is the leading worldwide cause of cancer-related deaths. Specifically, lung adenocarcinoma (LUAD) is the most prevalent lung cancer subtype resulting from genetic causes; LUAD has a 15% patient survival rate due to it commonly being...

Full description

Saved in:
Bibliographic Details
Main Authors: Sanjan S. Sarang, Catherine M. Cahill, Jack T. Rogers
Format: Article
Language:English
Published: MDPI AG 2025-05-01
Series:Biomolecules
Subjects:
lung adenocarcinoma
differential gene expression
multiomics
protein–protein interactions
early-stage markers
Online Access:https://www.mdpi.com/2218-273X/15/6/803
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items